Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1007/s40556-015-0027-1
Current Trends in Management of Fetal Growth Restriction
![](https://www.thieme-connect.de/media/10.1055-s-00057371/201403/lookinside/thumbnails/10-1007-s40556-015-0027-1_150027-1.jpg)
Abstract
Fetal growth restriction (FGR) or intrauterine growth restriction (IUGR) are the terms used for a fetus which has not attained its full growth potential. FGR fetus is associated with high perinatal and neonatal morbidity and mortality, besides long term neurological handicap because of in utero hypoxia. Three decades of research has indicated that almost all treatment strategies are ineffective in treating FGR. Panorama of management includes identifying women at risk, correct dating, distinguishing between a constitutionally small and a true FGR, monitoring for fetal hypoxia, growth, and a timely intervention to avoid death or damage.
Keyword
Fetal Growth Restriction - Intrauterine Fetal Growth Restriction - Intrauterine Growth RetardationPublication History
Received: 05 January 2015
Accepted: 05 February 2015
Article published online:
08 May 2023
© 2015. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India